ACTRN12611000429954
Active, not recruiting
未知
ongitudinal outcomes of hearing-impaired children: early versus later identification
ational Acoustic Laboratories, Australian Hearing0 sites468 target enrollmentApril 27, 2011
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hearing loss
- Sponsor
- ational Acoustic Laboratories, Australian Hearing
- Enrollment
- 468
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children in New South Wales, Victoria and Queensland who were born between 2002 and 2007, and who presented for hearing services at specialist paediatric hearing centres of Australian Hearing before 3 years of age.
- •Eligible participants will be deemed healthy.
Exclusion Criteria
- •Children who were over 3 years of age when they first received services from Australian Hearing.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Prevention of Bone loss in HIV-infected patients taking Highly Active Antiretroviral Therapy with ZoledronateHIV-related osteopeniaHIV-related osteoporosisInflammatory and Immune System - Acquired immune deficiency syndrome (AIDS / HIV)Musculoskeletal - OsteoporosisACTRN12605000208606Associate Professor A Grey70
Active, not recruiting
Phase 1
A randomised controlled trial to evaluate the feasibility of administering a drug called desmopressin to Intensive Care patients prior to procedures or radiological interventions, for prophylaxis against bleeding.EUCTR2016-001126-33-GBHS Blood and Transplant40
Active, not recruiting
Not Applicable
Comparative, placebo controlled, double-blind efficacy and safety study in patients with seborrhoeic dermatitis comparing a topical cream containing 2% Nicotinamide combined with either 0%, 0.5% or 1.0% GMCY with the placebo cream.Seborrhoeic Dermatitis.EUCTR2006-005637-37-GBAstion Danmark A/S
Completed
Not Applicable
A randomized, placebo-controlled, double blind human trial into the effect of Protecflor on gastroenteritis caused by attenuated E. Coligastroenteritistraveler's diarrhea1001796610004018NL-OMON37365allemand Human Nutrition60
Active, not recruiting
Phase 1
A clinical trial to investigate the effect of a drug called CNV1014802 on intense face pain and how safe the drug is.Trigeminal NeuralgiaMedDRA version: 14.1Level: LLTClassification code 10029227Term: Neuralgia trigeminalSystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2010-023963-16-LVConvergence Pharmaceuticals Ltd40